{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:25:57Z","timestamp":1777577157142,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["0887X1-4603"],"award-info":[{"award-number":["0887X1-4603"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.vaccine.2018.11.054","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T13:57:01Z","timestamp":1543240621000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Studying PCV impact on clinical presentation of otitis media helps to understand its pathogenesis"],"prefix":"10.1016","volume":"37","author":[{"given":"Shalom","family":"Ben-Shimol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noga","family":"Givon-Lavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Leibovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Dagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.11.054_b0005","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1473-3099(15)00549-6","article-title":"Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease","volume":"16","author":"Dagan","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.054_b0010","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/cid\/ciw347","article-title":"Impact of widespread introduction of pneumococcal conjugate vaccines on pneumococcal and nonpneumococcal otitis media","volume":"63","author":"Ben-Shimol","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.054_b0015","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/ciu683","article-title":"Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent\/13-valent PCV","volume":"59","author":"Ben-Shimol","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.054_b0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.11.054_b0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.11.054_b0030","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/cid\/cis799","article-title":"Acute otitis media replacement and recurrence in the Finnish otitis media vaccine trial","volume":"55","author":"Jokinen","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.054_b0035","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/infdis\/jit289","article-title":"Mixed pneumococcal-nontypeable Haemophilus influenzae otitis media is a distinct clinical entity with unique epidemiologic characteristics and pneumococcal serotype distribution","volume":"208","author":"Dagan","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.054_b0040","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/INF.0b013e318194e783","article-title":"Epidemiologic and microbiologic characteristics of culture-positive spontaneous otorrhea in children with acute otitis media","volume":"28","author":"Leibovitz","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.11.054_b0045","unstructured":"Central Bureau of Statistics. Statistical Abstract of Israel No. 63; 2012."},{"key":"10.1016\/j.vaccine.2018.11.054_b0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/AAC.44.1.43-50.2000","article-title":"Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children","volume":"44","author":"Dagan","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2018.11.054_b0055","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/21645515.2015.1095414","article-title":"Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel","volume":"12","author":"Ben-Shimol","year":"2016","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"10.1016\/j.vaccine.2018.11.054_b0060","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00727-17","article-title":"Pneumococcal phenotype and interaction with nontypeable haemophilus influenzae as determinants of otitis media progression","volume":"86","author":"Lewnard","year":"2018","journal-title":"Infect Immun"},{"issue":"486","key":"10.1016\/j.vaccine.2018.11.054_b0065","first-page":"e1","article-title":"Prospective evaluation of the aetiology of acute otitis media with spontaneous tympanic membrane perforation","volume":"23","author":"Marchisio","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2018.11.054_b0070","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/S0140-6736(03)13772-5","article-title":"Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomized study","volume":"361","author":"Veenhoven","year":"2003","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2018.11.054_b0075","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/jac\/dku158","article-title":"Frequent carriage of resistance mechanisms to beta-lactams and biofilm formation in Haemophilus influenzae causing treatment failure and recurrent otitis media in young children","volume":"69","author":"Garcia-Cobos","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2018.11.054_b0080","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01992-16","article-title":"N-acetyl-l-cysteine and cysteamine as new strategies against mixed biofilms of nonencapsulated streptococcus pneumoniae and nontypeable haemophilus influenzae","volume":"61","author":"Domenech","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2018.11.054_b0085","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1586\/eri.10.109","article-title":"Interspecies bacterial communication as a target for therapy in otitis media","volume":"8","author":"Armbruster","year":"2010","journal-title":"Expert Review of Anti-infective Therapy"},{"key":"10.1016\/j.vaccine.2018.11.054_b0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","article-title":"Biofilms: survival mechanisms of clinically relevant microorganisms","volume":"15","author":"Donlan","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2018.11.054_b0095","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/infdis\/jiu576","article-title":"Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae","volume":"211","author":"Dagan","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.054_b0100","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.11.054_b0105","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1016\/S2214-109X(14)70241-4","article-title":"Herd protection induced by pneumococcal conjugate vaccine","volume":"2","author":"Klugman","year":"2014","journal-title":"The Lancet Global Health"},{"key":"10.1016\/j.vaccine.2018.11.054_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170316","article-title":"Epidemiology of otitis media with spontaneous perforation of the tympanic membrane in young children and association with bacterial nasopharyngeal carriage, recurrences and pneumococcal vaccination in Catalonia, Spain - the prospective HERMES study","volume":"12","author":"Cilveti","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.11.054_b0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa0912254","article-title":"Treatment of acute otitis media in children under 2 years of age","volume":"364","author":"Hoberman","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T01:13:57Z","timestamp":1605489237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18315792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0264410X18315792"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Studying PCV impact on clinical presentation of otitis media helps to understand its pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}